Jump to navigation
Drug-maker GlaxoSmithKline is going to stop paying doctors worldwide for speaking engagements. And it'll stop setting targets for its drug reps.
Please log in to post comments.
Explore Stories that share this feature's tags
Wealth & Poverty Coverage
©2013 American Public Media